Affinage

PARD6G

Partitioning defective 6 homolog gamma · UniProt Q9BYG4

Length
376 aa
Mass
40.9 kDa
Annotated
2026-06-10
21 papers in source corpus 4 papers cited in narrative 6 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PARD6G (Par6γ) is a polarity scaffold protein that controls centrosomal protein composition and centrosome-dependent processes including ciliogenesis, microtubule organization, and centrosome reorientation during cell migration (PMID:23264737). It localizes specifically to the mother centriole through its C-terminus, independently of intact microtubules, the dynein/dynactin complex, and the PAR polarity complex (PMID:23264737). Depletion of Par6γ strips a large set of centrosomal proteins—including Par6α and p150(Glued)—from the centrosome, and Par6γ controls recruitment via association with Par6α acting through p150(Glued) (PMID:23264737). Although Par6γ binds Par3 and aPKC, these interactions are dispensable for its control of centrosomal composition (PMID:23264737). Beyond its centrosomal role, PARD6G regulates osteoblast proliferation and differentiation as a hub gene in an osteoblast-specific network (PMID:23300464), and acts as a tumor suppressor in head and neck squamous cell carcinoma, restraining cell proliferation and cell-cycle progression while shaping the anti-tumor immune microenvironment and response to anti-PD-1 therapy (PMID:42235314).

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 2012 High

    Established where Par6γ acts within the cell and what targets its localization, defining it as a mother-centriole-resident protein dependent on its own C-terminus rather than on canonical transport or polarity machinery.

    Evidence Immunofluorescence with truncation constructs plus microtubule disruption and siRNA of dynein/dynactin and PAR components

    PMID:23264737

    Open questions at the time
    • The molecular anchor at the mother centriole that recognizes the C-terminus is not identified
    • Structural basis of C-terminal targeting not resolved
  2. 2012 High

    Showed that Par6γ is required to maintain centrosomal protein composition and the downstream centrosome functions, moving it from a localized marker to a functional organizer of the centrosome.

    Evidence siRNA knockdown with ciliogenesis, microtubule organization, and scratch-wound centrosome reorientation readouts

    PMID:23264737

    Open questions at the time
    • The full set of dependent centrosomal proteins is not enumerated
    • Whether effects are direct or secondary to loss of Par6α/p150(Glued) is not fully separated
  3. 2012 High

    Distinguished required from dispensable Par6γ interactions, placing centrosomal composition control on a Par6α–p150(Glued) axis rather than the Par3/aPKC polarity pathway.

    Evidence Reciprocal Co-IP of Par6γ with Par3, aPKC, and Par6α plus epistatic siRNA of each partner

    PMID:23264737

    Open questions at the time
    • Whether Par6γ binds p150(Glued) directly or only via Par6α is unresolved
    • Functional purpose of the Par3/aPKC interactions remains unknown
  4. 2012 Medium

    Extended PARD6G function to tissue-level biology by identifying it as a regulator of osteoblast proliferation and differentiation.

    Evidence siRNA knockdown in osteoblast-lineage cells with proliferation/differentiation assays and co-expression network analysis

    PMID:23300464

    Open questions at the time
    • Whether the osteoblast phenotype depends on the centrosomal mechanism is untested
    • Single method per phenotype
  5. 2012 Low

    Raised the possibility that PARD6G expression can be deregulated in cancer through nearby viral integration.

    Evidence HBV-Alu PCR of viral-host junction and qPCR of PARD6G in paired HCC tumor/non-tumor tissue

    PMID:22989571

    Open questions at the time
    • Single patient case with correlative expression only, no functional experiment
    • No causal link between integration and tumorigenesis established
  6. 2025 Medium

    Defined PARD6G as a tumor suppressor in HNSCC that restrains proliferation and influences immunotherapy response, connecting its cell-intrinsic role to the tumor immune microenvironment.

    Evidence Overexpression/knockdown in HNSCC lines (proliferation, cell cycle) and syngeneic PARD6G-knockout tumor models with anti-PD-1 and immune infiltration profiling

    PMID:42235314

    Open questions at the time
    • The molecular link between centrosomal function and proliferation/immune effects is not defined
    • Mechanism of immune microenvironment remodeling not resolved

Open questions

Synthesis pass · forward-looking unresolved questions
  • How Par6γ's centrosomal scaffolding activity mechanistically connects to its tissue-specific roles in osteoblasts and tumor suppression remains unresolved.
  • No unifying mechanism connecting centrosome composition to proliferation control
  • Direct binding partner at the mother centriole unidentified

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 2
Localization
GO:0005815 microtubule organizing center 2 GO:0005856 cytoskeleton 1

Evidence

Reading pass · 6 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2012 Par6γ (PARD6G) localizes specifically to the mother centriole, and this localization requires the Par6γ C-terminus but is independent of intact microtubules, the dynein/dynactin complex, and components of the PAR polarity complex. Immunofluorescence localization, deletion/truncation constructs, pharmacological disruption of microtubules, siRNA depletion of dynein/dynactin and PAR complex components Journal of cell science High 23264737
2012 Depletion of Par6γ results in loss of a large number of centrosomal proteins, including Par6α and p150(Glued), from the centrosome, leading to defects in ciliogenesis, microtubule organization, and centrosome reorientation during cell migration. siRNA knockdown of Par6γ followed by immunofluorescence assessment of centrosomal protein composition, ciliogenesis assays, microtubule organization assays, and scratch-wound migration assays Journal of cell science High 23264737
2012 Par6γ interacts with Par3 and aPKC, but these interactions are not required for the regulation of centrosomal protein composition; Par6γ also associates with Par6α, which controls protein recruitment to the centrosome through p150(Glued). Co-immunoprecipitation of Par6γ with Par3, aPKC, and Par6α; siRNA depletion of Par3 and aPKC showing no effect on centrosomal composition; siRNA of Par6α showing loss of centrosomal protein recruitment Journal of cell science High 23264737
2012 Knockdown of Pard6g in osteoblast-lineage cells altered both osteoblast proliferation and differentiation, identifying PARD6G as a functional hub gene in an osteoblast-specific gene network. siRNA knockdown of Pard6g in osteoblast-lineage cells with proliferation and differentiation assays; co-expression network analysis in the Hybrid Mouse Diversity Panel PLoS genetics Medium 23300464
2012 HBV DNA integration upstream of the PARD6G locus was associated with overexpression of PARD6G in tumour versus non-tumour liver tissue in a hepatocellular carcinoma patient, suggesting PARD6G can be activated by nearby viral integration. HBV-Alu PCR sequencing of viral-host DNA junction, real-time PCR quantification of PARD6G expression in paired tumour/non-tumour tissues Journal of hepatology Low 22989571
2025 In vitro, PARD6G overexpression suppressed HNSCC cell proliferation and cell-cycle progression, while PARD6G knockdown promoted tumor growth; in vivo, PARD6G-deficient tumors exhibited accelerated growth and resistance to anti-PD-1 treatment accompanied by a reshaped immunosuppressive microenvironment. PARD6G overexpression and siRNA knockdown in HNSCC cell lines (proliferation, cell-cycle assays); syngeneic mouse tumor models with PARD6G knockout and anti-PD-1 treatment; immune infiltration profiling International immunopharmacology Medium 42235314

Source papers

Stage 0 corpus · 21 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2018 Insights into imprinting from parent-of-origin phased methylomes and transcriptomes. Nature genetics 86 30349119
2012 Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. International journal of oncology 83 22576693
2012 Systems genetic analysis of osteoblast-lineage cells. PLoS genetics 47 23300464
2010 Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 43 20682712
2012 PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer. American journal of cancer research 33 22957302
2015 Epigenome-Wide Association Study of Aggressive Behavior. Twin research and human genetics : the official journal of the International Society for Twin Studies 31 26508088
2020 Genome-Wide Epistatic Interaction Networks Affecting Feed Efficiency in Duroc and Landrace Pigs. Frontiers in genetics 30 32184802
2012 Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. Journal of hepatology 24 22989571
2011 A novel bayesian graphical model for genome-wide multi-SNP association mapping. Genetic epidemiology 24 22127647
2012 Par6γ is at the mother centriole and controls centrosomal protein composition through a Par6α-dependent pathway. Journal of cell science 19 23264737
2023 A genome-wide association analysis of loss of ambulation in dystrophinopathy patients suggests multiple candidate modifiers of disease severity. European journal of human genetics : EJHG 14 36935420
2018 Maternal 5mCpG Imprints at the PARD6G-AS1 and GCSAML Differentially Methylated Regions Are Decoupled From Parent-of-Origin Expression Effects in Multiple Human Tissues. Frontiers in genetics 14 29545821
2020 Genetically-regulated transcriptomics & copy number variation of proctitis points to altered mitochondrial and DNA repair mechanisms in individuals of European ancestry. BMC cancer 7 33008348
2022 Network Meta-Analysis of Chicken Microarray Data following Avian Influenza Challenge-A Comparison of Highly and Lowly Pathogenic Strains. Genes 6 35327988
2022 Introduction of loxP sites by electroporation in the mouse genome; a simple approach for conditional allele generation in complex targeting loci. BMC biotechnology 6 35549895
2025 Integrative analysis of DNA methylation, RNA sequencing, and genomic variants in the cancer genome atlas (TCGA) to predict endometrial cancer recurrence. Frontiers in genetics 2 40357366
2025 Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances. Cellular signalling 1 41110735
2023 Case report: Complete paternal isodisomy on chromosome 18 induces methylation changes in PARD6G-AS1 promotor in a case with arthrogryposis. Frontiers in genetics 1 38188501
2026 PARD6G mediates resistance to PD-1 immune checkpoint blockade in head and neck squamous cell carcinoma. International immunopharmacology 0 42235314
2025 The multi-omics signatures of telomere length in childhood. BMC genomics 0 39871190
2025 Comprehensive characterization of the competitive endogenous RNA network revealing its immune-related functions in hepatic ischemia-reperfusion injury. PloS one 0 40705804

Missed literature

Know a paper Affinage missed for PARD6G? Flag it for the maintainers and the community.

No submissions yet.